Vaccines

  • Your Selections:

Refine Results

date

Tags

GHIT Fund Announces Investments In Malaria, TB Diagnostics, NTD Treatment

Global Health Innovative Technology Fund: GHIT Fund Announces New Investments, Including Innovative Malaria Vaccine Targeting Two Deadliest Strains of the Disease The Global Health Innovative Technology Fund announced investments in two innovative malaria eradication tools, a new rapid diagnostic test that can identify active tuberculosis in HIV-positive patients, and efforts to develop…

U.S. Must Prepare For Potential Spread Of Zika Virus

New York Times: Zika Is Coming Peter J. Hotez, pediatrician and microbiologist at Texas Children’s Hospital, and dean of the National School of Tropical Medicine at Baylor College of Medicine “…If mosquitoes carrying the Zika virus reach the United States later this spring or summer, [Houston, New Orleans, Miami, Biloxi,…

CDC Will Continue Efforts To End Vaccine-Preventable Diseases

Atlanta Journal-Constitution: Global immunization: 50 Years of work and success Rebecca Martin, director of the CDC’s Center for Global Health “…CDC will continue working closely with governments and ministries of health in countries where disease takes a heavy toll and where immunization systems have gaps. … At the same time,…

MSF Delivers Petitions To Pfizer, GlaxoSmithKline Asking For Lower-Cost Pneumonia Vaccines

The Guardian: Shareholders urged to push for cheaper pneumonia drugs “Shareholders are being urged to use the annual general meetings of Pfizer and GlaxoSmithKline to put pressure on the companies to lower the price of their life-saving pneumonia vaccines…” (Kollewe, 4/27). Thomson Reuters Foundation: Charity urges price cut for pneumonia…

Investing In Vaccine Research, Innovation Critical To Achieving SDGs

Devex: Delivering the next generation of vaccines Cécile Vernant, head of E.U. advocacy for Deutsche Stiftung Weltbevoelkerung “…If we are serious about ending [malaria, HIV, TB, and other diseases of poverty] by 2030, then we will need new and innovative vaccines. … If we are to harness the latent potential…

Gates Foundation Awards $38M To Takeda Pharmaceuticals To Develop Low-Cost Polio Vaccine

Reuters: Gates Foundation backs Takeda polio vaccine with $38 million grant “Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries. … Chris Elias, the Gates Foundation’s head of global development, said the…

Blog Post Examines Questions Over Long-Term Safety Of Dengue Fever Vaccine

Humanosphere: Questions hover over Asia’s first dengue vaccination program in Philippines Humanosphere reporter Lisa Nikolau discusses the launch of a school-based immunization campaign in the Philippines to deliver the Dengvaxia vaccine to prevent dengue fever. She writes, “So far, the program appears to be running without difficulties, but some health…

Gates Foundation Announces Phase I Winners Of 16th Grand Challenges Explorations Initiative

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Bold Ideas to Tackle Big Problems in Global Health and Development: Grand Challenges Explorations Round 16 Steven Buchsbaum, deputy director, and Rebekah Neal, program officer, both for discovery & translational sciences in the Global Health Program of the Bill & Melinda Gates Foundation,…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.